Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals

Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Onex’s Investment in Unanet

Goodwin Procter advised Unanet and JMI Equity on the deal, while Latham & Watkins represented Onex. Unanet announced a new round of strategic financing from Onex Corporation...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Citrix Systems’ $16.5 Billion Acquisition of Vista Equity Partners and Evergreen Coast Capital’s Affiliates

Goodwin Procter advised Citrix Systems on the deal. Citrix Systems announced its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital Corporation, an affiliate of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

TIME’s Acquisition of Brandcast

Goodwin Procter advised TIME on the deal. TIME announced its acquisition of Brandcast, the leading no-code platform for creating and managing enterprise-grade websites. Through the acquisition, Brandcast’s...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pear Therapeutics’ $1.6 Billion Business Combination with Thimble Point Acquisition Corp.

Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here